收费全文 | 74586篇 |
免费 | 6021篇 |
国内免费 | 3273篇 |
耳鼻咽喉 | 300篇 |
儿科学 | 1196篇 |
妇产科学 | 818篇 |
基础医学 | 11521篇 |
口腔科学 | 843篇 |
临床医学 | 5385篇 |
内科学 | 18126篇 |
皮肤病学 | 1073篇 |
神经病学 | 5347篇 |
特种医学 | 1269篇 |
外国民族医学 | 10篇 |
外科学 | 5485篇 |
综合类 | 8593篇 |
现状与发展 | 14篇 |
预防医学 | 3820篇 |
眼科学 | 1137篇 |
药学 | 10991篇 |
11篇 | |
中国医学 | 2367篇 |
肿瘤学 | 5574篇 |
2023年 | 839篇 |
2022年 | 1205篇 |
2021年 | 2106篇 |
2020年 | 2029篇 |
2019年 | 2629篇 |
2018年 | 2625篇 |
2017年 | 2530篇 |
2016年 | 2603篇 |
2015年 | 2913篇 |
2014年 | 4703篇 |
2013年 | 5583篇 |
2012年 | 4357篇 |
2011年 | 4923篇 |
2010年 | 3841篇 |
2009年 | 3822篇 |
2008年 | 3851篇 |
2007年 | 3823篇 |
2006年 | 3427篇 |
2005年 | 2950篇 |
2004年 | 2597篇 |
2003年 | 2268篇 |
2002年 | 1908篇 |
2001年 | 1581篇 |
2000年 | 1382篇 |
1999年 | 1190篇 |
1998年 | 959篇 |
1997年 | 995篇 |
1996年 | 740篇 |
1995年 | 801篇 |
1994年 | 694篇 |
1993年 | 552篇 |
1992年 | 452篇 |
1991年 | 392篇 |
1990年 | 327篇 |
1989年 | 293篇 |
1988年 | 252篇 |
1987年 | 215篇 |
1985年 | 616篇 |
1984年 | 688篇 |
1983年 | 535篇 |
1982年 | 496篇 |
1981年 | 488篇 |
1980年 | 430篇 |
1979年 | 382篇 |
1978年 | 319篇 |
1977年 | 261篇 |
1976年 | 282篇 |
1975年 | 274篇 |
1974年 | 214篇 |
1973年 | 203篇 |
2. Rovatirelin orally administered to rats and dogs was rapidly absorbed and bioavailability was estimated to be 7.3 and 41.3%, respectively. The extent of plasma protein binding of rovatirelin in rats, dogs, and humans was low in all species (~15%). The permeability of rovatirelin from blood to brain (permeability-surface area) ranged from 1.04?±?0.14 to 1.29?±?0.28?μL/min/g in rats, and rovatirelin was stable in rat plasma and brain homogenates.
3. The metabolite pattern was qualitatively similar in vitro and in vivo. In animals, rovatirelin aminopentanoic acid (rovatirelin-acid), rovatirelin aminopentanone (rovatirelin-ketone), rovatirelin pyrrolidine (4S)-hydroxy (rovatirelin-OH), (thiazoylalanyl)methylpyrrolidine (TAMP), 3-(4-thiazoyl)-l-alanine (TA), and unknown metabolites were observed. In human hepatocytes, TAMP was mainly formed and no unique human metabolite was observed.
4. The radioactivity from administered [14C]rovatirelin was predominantly excreted in faeces in rats and dogs, and almost all radioactivity was recovered 168?h after administration. Absorption, brain penetration, and stability of rovatirelin in the brain were greater than for taltirelin.
5. Thus, orally administered rovatirelin is a potentially improved treatment for spinocerebellar degeneration compared with taltirelin. 相似文献
2. Firstly, cell viability and biochemical indicators were determined and the cell morphology was observed to confirm the cell injury and develop a cell hepatotoxicity model. Then, with the help of cell metabolomics based on UPLC-MS, the Genkwa Flos group samples were completely separated from the blank group samples in the score plots and seven upregulated as well as two down-regulated putative biomarkers in the loading plot were identified and confirmed. Besides, two signal molecules and four enzymes involved in biosynthesis pathway of lysophosphatidylcholine and the sphingosine kinase/sphingosine-1-phosphate pathway were determined to investigate the relationship between Genkwa Flos hepatotoxicity and these two classic pathways. Finally, the metabolic pathways related to specific biomarkers and two classic metabolic pathways were analyzed to explain the possible mechanism of Genkwa Flos hepatotoxicity.
3. Based on the results, lipid peroxidation and oxidative stress, phospholipase A2/lysophosphatidylcholine pathway, the disturbance of sphingosine-1-phosphate metabolic profile centered on sphingosine kinase/sphingosine-1-phosphate pathway and fatty acid metabolism might be critical participators in the progression of liver injury induced by Genkwa Flos. 相似文献